Related references
Note: Only part of the references are listed.New Insight into P-Glycoprotein as a Drug Target
Albert Breier et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Mechanisms of Drug Resistance in Cancer Chemotherapy: Coordinated Role and Regulation of Efflux Transporters and Metabolizing Enzymes
Ramya Krishna Vadlapatla et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Taxanes: Old drugs, new oral formulations
Rajni A. Jibodh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel
Jeroen J. M. A. Hendrikx et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Role of Glutathione in Cancer Progression and Chemoresistance
Nicola Traverso et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Targeting cellular metabolism to improve cancer therapeutics
Y. Zhao et al.
CELL DEATH & DISEASE (2013)
Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters
Yakun Chen et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
Karthika Natarajan et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Computational models for predicting substrates or inhibitors of P-glycoprotein
Lei Chen et al.
DRUG DISCOVERY TODAY (2012)
Contribution of tumoral and host solute carriers to clinical drug response
Jason A. Sprowl et al.
DRUG RESISTANCE UPDATES (2012)
Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
Nitzan Gonen et al.
DRUG RESISTANCE UPDATES (2012)
Amplification and overexpression of the ABCC3 (MRP3) gene in primary breast cancer
Laura Partanen et al.
GENES CHROMOSOMES & CANCER (2012)
Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
M. Yamasaki et al.
BRITISH JOURNAL OF CANCER (2011)
Contribution of Abcc10 (Mrp7) to In Vivo Paclitaxel Resistance as Assessed in Abcc10-/- Mice
Elizabeth A. Hopper-Borge et al.
CANCER RESEARCH (2011)
The Coordinated Role of CYP450 Enzymes and P-gp in Determining Cancer Resistance to Chemotherapy
Amalia Azzariti et al.
CURRENT DRUG METABOLISM (2011)
P-glycoprotein Substrate Models Using Support Vector Machines Based on a Comprehensive Data set
Zhi Wang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
Chung-Pu Wu et al.
MOLECULAR PHARMACEUTICS (2011)
A Critical Analysis of the Interplay between Cytochrome P450 3A and P-Glycoprotein: Recent Insights from Knockout and Transgenic Mice
Robert A. B. van Waterschoot et al.
PHARMACOLOGICAL REVIEWS (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR
Antonia H. Tolson et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Interaction of Tyrosine Kinase Inhibitors with the MDR-Related ABC Transporter Proteins
Xiao-Kun Wang et al.
CURRENT DRUG METABOLISM (2010)
Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors
Philip Lazarus et al.
DRUG METABOLISM REVIEWS (2010)
Octamer 4 (Oct4) Mediates Chemotherapeutic Drug Resistance in Liver Cancer Cells Through a Potential Oct4-AKT-ATP-Binding Cassette G2 Pathway
Xiao Qi Wang et al.
HEPATOLOGY (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Therapeutic implications of renal anionic drug transporters
Rosalinde Masereeuw et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Inhibition of multi-drug resistance of ovarian carcinoma by small interfering RNA targeting to MRP2 gene
Jia-jia Ma et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2009)
Glutathione dysregulation and the etiology and progression of human diseases
Nazzareno Ballatori et al.
BIOLOGICAL CHEMISTRY (2009)
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
James J. Farrell et al.
GASTROENTEROLOGY (2009)
P-glycoprotein expression in immortalised rat brain endothelial cells: comparisons following exogenously applied hydrogen peroxide and after hypoxia-reoxygenation
Samantha J. Robertson et al.
JOURNAL OF NEUROCHEMISTRY (2009)
The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
Sarah Shugarts et al.
PHARMACEUTICAL RESEARCH (2009)
How important is intestinal cytochrome P450 3A metabolism?
Antonius E. van Herwaarden et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer
Irma Meijerman et al.
CANCER TREATMENT REVIEWS (2008)
Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development
Shu-Feng Zhou et al.
CURRENT MEDICINAL CHEMISTRY (2008)
The solute carrier (SLC) complement of the human genome: Phylogenetic classification reveals four major families
Robert Fredriksson et al.
FEBS LETTERS (2008)
Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
Mitsunori Okabe et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Opinion - Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Paul D. Dobson et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Functional analysis of nonsynonymous single nucleotide polymorphism type ATP-binding cassette transmembrane transporter subfamily C member 3
Kazuhiro Kobayashi et al.
PHARMACOGENETICS AND GENOMICS (2008)
ABC multidrug transporters: structure, function and role in chemoresistance
Frances J. Sharom
PHARMACOGENOMICS (2008)
Distinct N-glycan glycosylation of P-glycoprotein isolated from the human uterine sarcoma cell line MES-SA/Dx5
D. A. Greer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2007)
Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways
Lukas Cerveny et al.
DRUG METABOLISM AND DISPOSITION (2007)
The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology
S. Harmsen et al.
CANCER TREATMENT REVIEWS (2007)
Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: Implications for interindividual variability in response to drugs
Bradley L. Urquhart et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Molecular basis of antifolate resistance
Yehuda G. Assaraf
CANCER AND METASTASIS REVIEWS (2007)
Free radicals and antioxidants in normal physiological functions and human disease
Marian Valko et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
ABCG2 expression, function, and promoter methylation in human multiple myeloma
Joel G. Turner et al.
BLOOD (2006)
Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs
Ingolf Cascorbi
PHARMACOLOGY & THERAPEUTICS (2006)
Multidrug resistance protein 2 is an important determinant of paclitaxel pharmacokinetics
Jurjen S. Lagas et al.
CLINICAL CANCER RESEARCH (2006)
RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells
Verena Materna et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis
Yehuda G. Assaraf
DRUG RESISTANCE UPDATES (2006)
Transport of glutathione and glutathione conjugates by MRP1
Susan P. C. Cole et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Cytochrome P450 pharmacogenetics and cancer
C Rodriguez-Antona et al.
ONCOGENE (2006)
Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer
S Nagar et al.
ONCOGENE (2006)
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy
K Takara et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Cytochrome P450s and other enzymes in drug metabolism and toxicity
FP Guengerich
AAPS JOURNAL (2006)
Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition
Gabriele Jedlitschky et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
PI Mackenzie et al.
PHARMACOGENETICS AND GENOMICS (2005)
Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists
B Ebert et al.
CARCINOGENESIS (2005)
ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolates
A Shafran et al.
CANCER RESEARCH (2005)
Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells
V Materna et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense
EM Leslie et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Role of the breast cancer resistance protein (ABCG2) in drug transport
QC Mao et al.
AAPS JOURNAL (2005)
Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel
FK Engels et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
The ABC transporter structure and mechanism: perspectives on recent research
PM Jones et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins - Introduction
MA Hediger et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
The MRP-related and BCRP/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation
A Haimeur et al.
CURRENT DRUG METABOLISM (2004)
Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs
YH Liang et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: Prominent roles for CYP3A and CYP2D6
Z Desta et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1) - Evidence that a tri-glutathione conjugate is required
EM Leslie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias
Z Benderra et al.
CLINICAL CANCER RESEARCH (2004)
Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function
A Suvannasankha et al.
LEUKEMIA (2004)
The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme
P Krishnamurthy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survival
A Suvannasankha et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Preclinical pharmacology of the taxanes: Implications of the differences
J Gligorov et al.
ONCOLOGIST (2004)
Induction of drug metabolism: The role of nuclear receptors
C Handschin et al.
PHARMACOLOGICAL REVIEWS (2003)
The role of glutathione-S-transferase in anti-cancer drug resistance
DM Townsend et al.
ONCOGENE (2003)
The MRP family of drug efflux pumps
GD Kruh et al.
ONCOGENE (2003)
Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin
B Liedert et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
The role of multidrug, transporters in drug availability, metabolism and toxicity
A Bodó et al.
TOXICOLOGY LETTERS (2003)
Bile salt transporters: Molecular characterization, function, and regulation
M Trauner et al.
PHYSIOLOGICAL REVIEWS (2003)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
AH Schinkel et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter -: Modulation of substrate specificity by a point mutation
C Özvegy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1)
Y Honjo et al.
CANCER BIOLOGY & THERAPY (2002)
Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1
T Hegedüs et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization
K Kage et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Glutathione conjugates and their synthetic derivatives as inhibitors of glutathione-dependent enzymes involved in cancer and drug resistance
D Burg et al.
DRUG METABOLISM REVIEWS (2002)
Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3)
N Zelcer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene
KJ Bailey-Dell et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2001)
Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells
C Özvegy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Nucleoside analogues: mechanisms of drug resistance and reversal strategies
CM Galmarini et al.
LEUKEMIA (2001)
Modulation of oral bioavailability of anticancer drugs:: from mouse to man
JHM Schellens et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2000)
A family of drug transporters: The multidrug resistance-associated proteins
P Borst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
